Abstract:Background: Blastocystis, the most prevalent eukaryotic gut microbe in humans, has a global distribution. Studies have linked its presence with distinct gut microbiome and metabolome profiles compared to those where the organism is absent. However, the in vivo effect of antibiotics on Blastocystis and the surrounding gut microbiome remains understudied. This case study aimed to explore how antibiotic consumption influences the presence of Blastocystis and the subsequent changes in the gut microbiome and metabolome of an individual with irritable bowel syndrome (IBS). Methods: Stool samples from an IBS patient, collected at various time points, were tested for Blastocystis presence using RT-PCR targeting the SSUrRNA gene, followed by sequencing of positive samples. Illumina sequencing determined the gut microbiome composition, while one-dimensional proton NMR spectroscopy analysed the metabolome composition. Statistical analyses were conducted to identify relationships between antibiotic consumption, bacterial diversity, metabolome composition, and Blastocystis presence. Results: Antibiotics significantly impacted the gut microbiome, with diversity declining early in the antibiotic course, then recovering later and post-course. Blastocystis was detected early, late, and post-course but not mid-course, coinciding with the decline in bacterial diversity. No significant differences were observed between Blastocystis-positive and Blastocystis-negative samples. However, bacterial composition significantly differed between samples collected before, early, and after the antibiotic course compared to those collected mid-course. Metabolite groups, including short-chain fatty acids, amino acids, and succinate, exhibited changes throughout the antibiotic course, indicating that gut metabolite composition is affected by antibiotic consumption. Discussion/Conclusion: While antibiotics did not significantly impact Blastocystis colonisation, they did cause a mid-course decline in microbial diversity and Blastocystis presence. The study also revealed significant alterations in important metabolites such as SCFAs and amino acids throughout the antibiotic course, with an altered metabolome observed post-course. This case study underscores the complex interactions between antibiotics, gut microbiota, and metabolites, highlighting the resilience of Blastocystis in the gut ecosystem.

Oh My Aching Gut: Irritable Bowel Syndrome, Blastocystis, and Asymptomatic Infection

Blastocystis and its pathogenic potential: latest aspects

[Progress of researches on Blastocystis hominis infection among patients with inflammatory bowel disease and irritable bowel syndrome]

Irritable Bowel Syndrome Associated with Blastocystis hominis or Without Relationship to It? A Case–Control Study and Minireview

Microbiome and Its Role in Irritable Bowel Syndrome

Epidemiology and subtype distribution of Blastocystis in humans: A review

Blastocystis: A Mysterious Member of the Gut Microbiome

An Update on Blastocystis: Possible Mechanisms of Blastocystis-Mediated Colorectal Cancer

Intestinal Microecology and Quality of Life in Irritable Bowel Syndrome Patients

Investigation of gut microbiota composition in humans carrying blastocystis subtypes 1 and 2 and Entamoeba hartmanni

Association of Blastocystis ST6 with higher protease activity among symptomatic subjects

Transcriptomic and Metabolomic Correlates of Increased Colonic Permeability in Postinfection Irritable Bowel Syndrome

Interactions Between a Pathogenic Blastocystis Subtype and Gut Microbiota: in Vitro and in Vivo Studies

Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome

The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome

Intestinal microbiota analysis of different Blastocystis subtypes and Blastocystis-negative individuals in Taiwan

Blastocystis hominis-associated Acute Appendicular Peritonitis in a 9-Year-old Boy: A Case Report and a Comprehensive Review of the Literature

The impact of antibiotics on the presence of the protozoan anaerobe Blastocystis and the surrounding microbiome: a case study

Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites

Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome

Fecal Proteolytic Bacteria and Staphylococcal Superantigens are Associated with Abdominal Pain Severity in Irritable Bowel Syndrome